EDUCATE: The MEDTRONIC Endeavor Drug Eluting Stenting: Understanding Care, Antiplatelet Agents and Thrombotic Events
Completed · Phase 4 · Has a placebo group
Conditions studied: Coronary Artery Disease
In brief
EDUCATE is a prospective, multi-center study designed to collect real-world safety and clinical outcomes in subjects receiving one or more Endeavor Zotarolimus-Eluting Stents and either clopidogrel and aspirin or prasugrel and aspirin as part of a dual antiplatelet therapy (DAPT) drug regimen.
Key facts
- Study ID
- NCT01069003
- Run by
- Medtronic Vascular
- People needed
- 2272
- Starts
- 2010-04-01
- Expected to finish
- 2014-04-01
- Last updated by the study team
- 2016-01-20
Who can join
Age: 19 and older. Sex: any. Healthy volunteers: not accepted.
Where it is running
- AnMed Health Medical Center — Anderson, South Carolina, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.